Results
1 -
2 of
2
(Click
here to explore results)
- Two-stage one-pot synthetic strategy for the key triazone-triazole intermediate of ensitrelvir (S-217622), an oral clinical candidate for treating COVID-19. Wei Hu, Xiang Zhang, Yuanchang Liu, Teng Liu, Jiale Wen, Xiaopeng Peng, Xin Xie, Weiming Chen
, RSC Adv.
, 2022
, 12
, 34808
- Small change for big improvement in the preparation of the key intermediate N
1, N
3-disubstituted 1,3,5-triazone of ensitrelvir. Wei Hu, Yuanchang Liu, Xiang Zhang, Panpan Zheng, Feifei Yang, Guangyang Guo, Xin Xie, Jiuzhong Huang, Weiming Chen
, RSC Adv.
, 2023
, 13
, 3688